| __timestamp | CRISPR Therapeutics AG | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 56292000 |
| Thursday, January 1, 2015 | 12573000 | 74277000 |
| Friday, January 1, 2016 | 42238000 | 122721000 |
| Sunday, January 1, 2017 | 69800000 | 109749000 |
| Monday, January 1, 2018 | 113773000 | 145283000 |
| Tuesday, January 1, 2019 | 179362000 | 131711000 |
| Wednesday, January 1, 2020 | 266946000 | 181157000 |
| Friday, January 1, 2021 | 438633000 | 272744000 |
| Saturday, January 1, 2022 | 461645000 | 397518000 |
| Sunday, January 1, 2023 | 387332000 | 571011000 |
| Monday, January 1, 2024 | 320653000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, Insmed Incorporated and CRISPR Therapeutics AG have been at the forefront, investing heavily in R&D to drive breakthroughs. From 2014 to 2023, Insmed's R&D expenses surged by over 900%, peaking in 2023 with a 57% increase from the previous year. Meanwhile, CRISPR Therapeutics AG saw a remarkable 25% average annual growth in R&D spending, with a notable peak in 2022. This trend underscores the relentless pursuit of cutting-edge therapies and technologies. As these companies continue to push the boundaries of science, their R&D investments highlight the critical role of sustained funding in achieving transformative medical advancements.
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Gilead Sciences, Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Viatris Inc. vs Insmed Incorporated
Analyzing R&D Budgets: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CRISPR Therapeutics AG
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for CRISPR Therapeutics AG and Bausch Health Companies Inc.
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending